2018-2023 Global Nanopharmaceuticals Consumption Market Report

October 2018 | 176 pages | ID: 22949D563C7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Nanopharmaceuticals market for 2018-2023.
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
USA is a huge market, and the total sum of the industry is more than 8756.7 million USD in 2015. At the same time, this industry continuously increases, with the development of global economy.
USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.

Over the next five years, LPI(LP Information) projects that Nanopharmaceuticals will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanopharmaceuticals market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Liposomes
• Polymeric Micelles
• Solid Lipid Nanoparticles
• Microemulsion and Nnanoemulsion
• Nanosuspension

Segmentation by application:

• Cancer and Tumor
• Autoimmune Disorders
• Inflammation
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Merck
• Pfizer
• Novartis
• Abbott
• GlaxoSmithKline
• Roche
• Sanofi
• Eli Lilly
• Astrazeneca
• Johnson & Johnson
• Celgene
• Novavax
• Stryker
• Gilead Sciences
• OSI Pharmaceuticals
• Kadmon Pharmaceuticals
• Samyang Biopharm
• Mitsubishi Pharma
• Kaken Pharmaceutical
• Selecta Biosciences
• Par Pharmaceutical
• Cerulean Pharma
• Navidea Biopharmaceuticals
• Lummy

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Nanopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Nanopharmaceuticals market by identifying its various subsegments.
• Focuses on the key global Nanopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Nanopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Nanopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL NANOPHARMACEUTICALS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nanopharmaceuticals Consumption 2013-2023
  2.1.2 Nanopharmaceuticals Consumption CAGR by Region
2.2 Nanopharmaceuticals Segment by Type
  2.2.1 Liposomes
  2.2.2 Polymeric Micelles
  2.2.3 Solid Lipid Nanoparticles
  2.2.4 Microemulsion and Nnanoemulsion
  2.2.5 Nanosuspension
2.3 Nanopharmaceuticals Consumption by Type
  2.3.1 Global Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
  2.3.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Nanopharmaceuticals Sale Price by Type (2013-2018)
2.4 Nanopharmaceuticals Segment by Application
  2.4.1 Cancer and Tumor
  2.4.2 Autoimmune Disorders
  2.4.3 Inflammation
  2.4.4 Others
2.5 Nanopharmaceuticals Consumption by Application
  2.5.1 Global Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
  2.5.2 Global Nanopharmaceuticals Value and Market Share by Application (2013-2018)
  2.5.3 Global Nanopharmaceuticals Sale Price by Application (2013-2018)

3 GLOBAL NANOPHARMACEUTICALS BY PLAYERS

3.1 Global Nanopharmaceuticals Sales Market Share by Players
  3.1.1 Global Nanopharmaceuticals Sales by Players (2016-2018)
  3.1.2 Global Nanopharmaceuticals Sales Market Share by Players (2016-2018)
3.2 Global Nanopharmaceuticals Revenue Market Share by Players
  3.2.1 Global Nanopharmaceuticals Revenue by Players (2016-2018)
  3.2.2 Global Nanopharmaceuticals Revenue Market Share by Players (2016-2018)
3.3 Global Nanopharmaceuticals Sale Price by Players
3.4 Global Nanopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Nanopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Nanopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NANOPHARMACEUTICALS BY REGIONS

4.1 Nanopharmaceuticals by Regions
  4.1.1 Global Nanopharmaceuticals Consumption by Regions
  4.1.2 Global Nanopharmaceuticals Value by Regions
4.2 Americas Nanopharmaceuticals Consumption Growth
4.3 APAC Nanopharmaceuticals Consumption Growth
4.4 Europe Nanopharmaceuticals Consumption Growth
4.5 Middle East & Africa Nanopharmaceuticals Consumption Growth

5 AMERICAS

5.1 Americas Nanopharmaceuticals Consumption by Countries
  5.1.1 Americas Nanopharmaceuticals Consumption by Countries (2013-2018)
  5.1.2 Americas Nanopharmaceuticals Value by Countries (2013-2018)
5.2 Americas Nanopharmaceuticals Consumption by Type
5.3 Americas Nanopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Nanopharmaceuticals Consumption by Countries
  6.1.1 APAC Nanopharmaceuticals Consumption by Countries (2013-2018)
  6.1.2 APAC Nanopharmaceuticals Value by Countries (2013-2018)
6.2 APAC Nanopharmaceuticals Consumption by Type
6.3 APAC Nanopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Nanopharmaceuticals by Countries
  7.1.1 Europe Nanopharmaceuticals Consumption by Countries (2013-2018)
  7.1.2 Europe Nanopharmaceuticals Value by Countries (2013-2018)
7.2 Europe Nanopharmaceuticals Consumption by Type
7.3 Europe Nanopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nanopharmaceuticals by Countries
  8.1.1 Middle East & Africa Nanopharmaceuticals Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Nanopharmaceuticals Value by Countries (2013-2018)
8.2 Middle East & Africa Nanopharmaceuticals Consumption by Type
8.3 Middle East & Africa Nanopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Nanopharmaceuticals Distributors
10.3 Nanopharmaceuticals Customer

11 GLOBAL NANOPHARMACEUTICALS MARKET FORECAST

11.1 Global Nanopharmaceuticals Consumption Forecast (2018-2023)
11.2 Global Nanopharmaceuticals Forecast by Regions
  11.2.1 Global Nanopharmaceuticals Forecast by Regions (2018-2023)
  11.2.2 Global Nanopharmaceuticals Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Nanopharmaceuticals Forecast by Type
11.8 Global Nanopharmaceuticals Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Merck
  12.1.1 Company Details
  12.1.2 Nanopharmaceuticals Product Offered
  12.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Merck News
12.2 Pfizer
  12.2.1 Company Details
  12.2.2 Nanopharmaceuticals Product Offered
  12.2.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Pfizer News
12.3 Novartis
  12.3.1 Company Details
  12.3.2 Nanopharmaceuticals Product Offered
  12.3.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Novartis News
12.4 Abbott
  12.4.1 Company Details
  12.4.2 Nanopharmaceuticals Product Offered
  12.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Abbott News
12.5 GlaxoSmithKline
  12.5.1 Company Details
  12.5.2 Nanopharmaceuticals Product Offered
  12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 GlaxoSmithKline News
12.6 Roche
  12.6.1 Company Details
  12.6.2 Nanopharmaceuticals Product Offered
  12.6.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Roche News
12.7 Sanofi
  12.7.1 Company Details
  12.7.2 Nanopharmaceuticals Product Offered
  12.7.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Sanofi News
12.8 Eli Lilly
  12.8.1 Company Details
  12.8.2 Nanopharmaceuticals Product Offered
  12.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Eli Lilly News
12.9 Astrazeneca
  12.9.1 Company Details
  12.9.2 Nanopharmaceuticals Product Offered
  12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Astrazeneca News
12.10 Johnson & Johnson
  12.10.1 Company Details
  12.10.2 Nanopharmaceuticals Product Offered
  12.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Johnson & Johnson News
12.11 Celgene
12.12 Novavax
12.13 Stryker
12.14 Gilead Sciences
12.15 OSI Pharmaceuticals
12.16 Kadmon Pharmaceuticals
12.17 Samyang Biopharm
12.18 Mitsubishi Pharma
12.19 Kaken Pharmaceutical
12.20 Selecta Biosciences
12.21 Par Pharmaceutical
12.22 Cerulean Pharma
12.23 Navidea Biopharmaceuticals
12.24 Lummy

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nanopharmaceuticals
Table Product Specifications of Nanopharmaceuticals
Figure Nanopharmaceuticals Report Years Considered
Figure Market Research Methodology
Figure Global Nanopharmaceuticals Consumption Growth Rate 2013-2023 (K MT)
Figure Global Nanopharmaceuticals Value Growth Rate 2013-2023 ($ Millions)
Table Nanopharmaceuticals Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Liposomes
Table Major Players of Liposomes
Figure Product Picture of Polymeric Micelles
Table Major Players of Polymeric Micelles
Figure Product Picture of Solid Lipid Nanoparticles
Table Major Players of Solid Lipid Nanoparticles
Figure Product Picture of Microemulsion and Nnanoemulsion
Table Major Players of Microemulsion and Nnanoemulsion
Figure Product Picture of Nanosuspension
Table Major Players of Nanosuspension
Table Global Consumption Sales by Type (2013-2018)
Table Global Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
Figure Global Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
Table Global Nanopharmaceuticals Revenue by Type (2013-2018) ($ million)
Table Global Nanopharmaceuticals Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Nanopharmaceuticals Value Market Share by Type (2013-2018)
Table Global Nanopharmaceuticals Sale Price by Type (2013-2018)
Figure Nanopharmaceuticals Consumed in Cancer and Tumor
Figure Global Nanopharmaceuticals Market: Cancer and Tumor (2013-2018) (K MT)
Figure Global Nanopharmaceuticals Market: Cancer and Tumor (2013-2018) ($ Millions)
Figure Global Cancer and Tumor YoY Growth ($ Millions)
Figure Nanopharmaceuticals Consumed in Autoimmune Disorders
Figure Global Nanopharmaceuticals Market: Autoimmune Disorders (2013-2018) (K MT)
Figure Global Nanopharmaceuticals Market: Autoimmune Disorders (2013-2018) ($ Millions)
Figure Global Autoimmune Disorders YoY Growth ($ Millions)
Figure Nanopharmaceuticals Consumed in Inflammation
Figure Global Nanopharmaceuticals Market: Inflammation (2013-2018) (K MT)
Figure Global Nanopharmaceuticals Market: Inflammation (2013-2018) ($ Millions)
Figure Global Inflammation YoY Growth ($ Millions)
Figure Nanopharmaceuticals Consumed in Others
Figure Global Nanopharmaceuticals Market: Others (2013-2018) (K MT)
Figure Global Nanopharmaceuticals Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
Figure Global Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
Table Global Nanopharmaceuticals Value by Application (2013-2018)
Table Global Nanopharmaceuticals Value Market Share by Application (2013-2018)
Figure Global Nanopharmaceuticals Value Market Share by Application (2013-2018)
Table Global Nanopharmaceuticals Sale Price by Application (2013-2018)
Table Global Nanopharmaceuticals Sales by Players (2016-2018) (K MT)
Table Global Nanopharmaceuticals Sales Market Share by Players (2016-2018)
Figure Global Nanopharmaceuticals Sales Market Share by Players in 2016
Figure Global Nanopharmaceuticals Sales Market Share by Players in 2017
Table Global Nanopharmaceuticals Revenue by Players (2016-2018) ($ Millions)
Table Global Nanopharmaceuticals Revenue Market Share by Players (2016-2018)
Figure Global Nanopharmaceuticals Revenue Market Share by Players in 2016
Figure Global Nanopharmaceuticals Revenue Market Share by Players in 2017
Table Global Nanopharmaceuticals Sale Price by Players (2016-2018)
Figure Global Nanopharmaceuticals Sale Price by Players in 2017
Table Global Nanopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
Table Players Nanopharmaceuticals Products Offered
Table Nanopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Nanopharmaceuticals Consumption by Regions 2013-2018 (K MT)
Table Global Nanopharmaceuticals Consumption Market Share by Regions 2013-2018
Figure Global Nanopharmaceuticals Consumption Market Share by Regions 2013-2018
Table Global Nanopharmaceuticals Value by Regions 2013-2018 ($ Millions)
Table Global Nanopharmaceuticals Value Market Share by Regions 2013-2018
Figure Global Nanopharmaceuticals Value Market Share by Regions 2013-2018
Figure Americas Nanopharmaceuticals Consumption 2013-2018 (K MT)
Figure Americas Nanopharmaceuticals Value 2013-2018 ($ Millions)
Figure APAC Nanopharmaceuticals Consumption 2013-2018 (K MT)
Figure APAC Nanopharmaceuticals Value 2013-2018 ($ Millions)
Figure Europe Nanopharmaceuticals Consumption 2013-2018 (K MT)
Figure Europe Nanopharmaceuticals Value 2013-2018 ($ Millions)
Figure Middle East & Africa Nanopharmaceuticals Consumption 2013-2018 (K MT)
Figure Middle East & Africa Nanopharmaceuticals Value 2013-2018 ($ Millions)
Table Americas Nanopharmaceuticals Consumption by Countries (2013-2018) (K MT)
Table Americas Nanopharmaceuticals Consumption Market Share by Countries (2013-2018)
Figure Americas Nanopharmaceuticals Consumption Market Share by Countries in 2017
Table Americas Nanopharmaceuticals Value by Countries (2013-2018) ($ Millions)
Table Americas Nanopharmaceuticals Value Market Share by Countries (2013-2018)
Figure Americas Nanopharmaceuticals Value Market Share by Countries in 2017
Table Americas Nanopharmaceuticals Consumption by Type (2013-2018) (K MT)
Table Americas Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
Figure Americas Nanopharmaceuticals Consumption Market Share by Type in 2017
Table Americas Nanopharmaceuticals Consumption by Application (2013-2018) (K MT)
Table Americas Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
Figure Americas Nanopharmaceuticals Consumption Market Share by Application in 2017
Figure United States Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure United States Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Canada Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Canada Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Mexico Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Mexico Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Table APAC Nanopharmaceuticals Consumption by Countries (2013-2018) (K MT)
Table APAC Nanopharmaceuticals Consumption Market Share by Countries (2013-2018)
Figure APAC Nanopharmaceuticals Consumption Market Share by Countries in 2017
Table APAC Nanopharmaceuticals Value by Countries (2013-2018) ($ Millions)
Table APAC Nanopharmaceuticals Value Market Share by Countries (2013-2018)
Figure APAC Nanopharmaceuticals Value Market Share by Countries in 2017
Table APAC Nanopharmaceuticals Consumption by Type (2013-2018) (K MT)
Table APAC Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
Figure APAC Nanopharmaceuticals Consumption Market Share by Type in 2017
Table APAC Nanopharmaceuticals Consumption by Application (2013-2018) (K MT)
Table APAC Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
Figure APAC Nanopharmaceuticals Consumption Market Share by Application in 2017
Figure China Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure China Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Japan Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Japan Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Korea Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Korea Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Southeast Asia Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure India Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure India Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Australia Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Australia Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Table Europe Nanopharmaceuticals Consumption by Countries (2013-2018) (K MT)
Table Europe Nanopharmaceuticals Consumption Market Share by Countries (2013-2018)
Figure Europe Nanopharmaceuticals Consumption Market Share by Countries in 2017
Table Europe Nanopharmaceuticals Value by Countries (2013-2018) ($ Millions)
Table Europe Nanopharmaceuticals Value Market Share by Countries (2013-2018)
Figure Europe Nanopharmaceuticals Value Market Share by Countries in 2017
Table Europe Nanopharmaceuticals Consumption by Type (2013-2018) (K MT)
Table Europe Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
Figure Europe Nanopharmaceuticals Consumption Market Share by Type in 2017
Table Europe Nanopharmaceuticals Consumption by Application (2013-2018) (K MT)
Table Europe Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
Figure Europe Nanopharmaceuticals Consumption Market Share by Application in 2017
Figure Germany Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Germany Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure France Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure France Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure UK Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure UK Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Italy Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Italy Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Russia Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Russia Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Spain Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Spain Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Nanopharmaceuticals Consumption by Countries (2013-2018) (K MT)
Table Middle East & Africa Nanopharmaceuticals Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Nanopharmaceuticals Consumption Market Share by Countries in 2017
Table Middle East & Africa Nanopharmaceuticals Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Nanopharmaceuticals Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Nanopharmaceuticals Value Market Share by Countries in 2017
Table Middle East & Africa Nanopharmaceuticals Consumption by Type (2013-2018) (K MT)
Table Middle East & Africa Nanopharmaceuticals Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Nanopharmaceuticals Consumption Market Share by Type in 2017
Table Middle East & Africa Nanopharmaceuticals Consumption by Application (2013-2018) (K MT)
Table Middle East & Africa Nanopharmaceuticals Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Nanopharmaceuticals Consumption Market Share by Application in 2017
Figure Egypt Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Egypt Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure South Africa Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure South Africa Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Israel Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Israel Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure Turkey Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure Turkey Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Nanopharmaceuticals Consumption Growth 2013-2018 (K MT)
Figure GCC Countries Nanopharmaceuticals Value Growth 2013-2018 ($ Millions)
Table Nanopharmaceuticals Distributors List
Table Nanopharmaceuticals Customer List
Figure Global Nanopharmaceuticals Consumption Growth Rate Forecast (2018-2023) (K MT)
Figure Global Nanopharmaceuticals Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Nanopharmaceuticals Consumption Forecast by Countries (2018-2023) (K MT)
Table Global Nanopharmaceuticals Consumption Market Forecast by Regions
Table Global Nanopharmaceuticals Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Nanopharmaceuticals Value Market Share Forecast by Regions
Figure Americas Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Americas Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure APAC Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure APAC Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Europe Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Europe Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Middle East & Africa Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Middle East & Africa Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure United States Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure United States Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Canada Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Canada Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Mexico Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Mexico Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Brazil Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Brazil Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure China Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure China Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Japan Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Japan Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Korea Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Korea Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Southeast Asia Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Southeast Asia Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure India Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure India Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Australia Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Australia Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Germany Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Germany Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure France Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure France Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure UK Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure UK Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Italy Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Italy Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Russia Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Russia Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Spain Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Spain Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Egypt Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Egypt Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure South Africa Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure South Africa Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Israel Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Israel Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure Turkey Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure Turkey Nanopharmaceuticals Value 2018-2023 ($ Millions)
Figure GCC Countries Nanopharmaceuticals Consumption 2018-2023 (K MT)
Figure GCC Countries Nanopharmaceuticals Value 2018-2023 ($ Millions)
Table Global Nanopharmaceuticals Consumption Forecast by Type (2018-2023) (K MT)
Table Global Nanopharmaceuticals Consumption Market Share Forecast by Type (2018-2023)
Table Global Nanopharmaceuticals Value Forecast by Type (2018-2023) ($ Millions)
Table Global Nanopharmaceuticals Value Market Share Forecast by Type (2018-2023)
Table Global Nanopharmaceuticals Consumption Forecast by Application (2018-2023) (K MT)
Table Global Nanopharmaceuticals Consumption Market Share Forecast by Application (2018-2023)
Table Global Nanopharmaceuticals Value Forecast by Application (2018-2023) ($ Millions)
Table Global Nanopharmaceuticals Value Market Share Forecast by Application (2018-2023)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Nanopharmaceuticals Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Nanopharmaceuticals Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Nanopharmaceuticals Market Share (2016-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Nanopharmaceuticals Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Nanopharmaceuticals Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Nanopharmaceuticals Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Nanopharmaceuticals Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Nanopharmaceuticals Market Share (2016-2018)
Table Astrazeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astrazeneca Nanopharmaceuticals Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Nanopharmaceuticals Market Share (2016-2018)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Stryker Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OSI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kadmon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Samyang Biopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kaken Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Selecta Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Par Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cerulean Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lummy Basic Information, Manufacturing Base, Sales Area and Its Competitors